Prevail Therapeutics Competitors and Similar CompaniesClear all
Prevail Therapeutics's competitors and similar companies include Y-mAbs Therapeutics.
 Prevail Therapeutics Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease. |  Y-mAbs Therapeutics Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets. | |
Founding Date | Founding Date 2017 | Founding Date 2014 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New York, US HQ | Locations New York, US HQ Copenhagen, DK Nutley, US |
Employees | Employees 489% increase | Employees 3239% increase |
Valuation ($) | Valuation ($) 787.7 m | Valuation ($) 657 m |
Financial | ||
Net income | Net income ($63.2m) (FY, 2019) | Net income ($29.7m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 125m | Total funding raised $ 80m |
For sources of this data, please see the company profile
View Company Profiles
Y-mAbs Therapeutics
HQ
New York, US
Employees
32↑ 39% increase
Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.
View company